IMUX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 115616 min ago

@ $1.320

Wydano: 14 vas. 2024 @ 22:57

Zwrot: 3.79%

Poprzedni sygnał: vas. 9 - 16:39

Poprzedni sygnał: Sprzedaż

Zwrot: 4.35 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases...

Stats
Dzisiejszy wolumen	112 207
Średni wolumen	511 911
Kapitalizacja rynkowa	123.20M
EPS	$0 ( 2024-02-22 )
Następna data zysków	( $-0.270 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.650
ATR14	$0.00700 (0.51%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-04	Howson Tamar D	Buy	64 959	Stock Option
2024-03-04	Howson Tamar D	Sell	10 000	Stock Option
2024-03-04	Howson Tamar D	Sell	10 000	Stock Option
2024-03-04	Howson Tamar D	Sell	9 986	Stock Option
2024-03-04	Howson Tamar D	Sell	15 000	Stock Option

INSIDER POWER
44.47
Last 97 transactions
Buy: 5 390 136 \| Sell: 1 509 904

Wolumen Korelacja

Długi: 0.18 (neutral)

Krótki: 0.00 (neutral)

Signal:(49.556) Neutral

Immunic Inc Korelacja

10 Najbardziej pozytywne korelacje
TOP	0.913
HOWL	0.902
BNIXU	0.887
GAINL	0.884
OLMA	0.874
IPKW	0.873
EOLS	0.87
ALGS	0.867
LILAK	0.867
ISNS	0.866

10 Najbardziej negatywne korelacje
MMAC	-0.89
BOCH	-0.886
SHSP	-0.857
PEP	-0.832
NETE	-0.826
AMRB	-0.825

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Immunic Inc Korelacja - Waluta/Towar

-0.82
( strong negative )

-0.36
( neutral )

0.00
( neutral )

-0.37
( neutral )

0.00
( neutral )

0.73
( moderate )

Immunic Inc Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-111 000 (0.00 %)
EPS:	$-2.11

FY	2023
Przychody:	$0
Zysk brutto:	$-111 000 (0.00 %)
EPS:	$-2.11

FY	2022
Przychody:	$0
Zysk brutto:	$-77 000.00 (0.00 %)
EPS:	$-4.85

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-3.93

Financial Reports:

No articles found.

Immunic Inc

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.

Aktualne aktualizacje dla Immunic Inc [IMUX]

Upcoming Earnings Alert